Grant, J. E., Kushner, M. G., & Kim, S. W. (2002). Pathological gambling and alcohol use disorder. Alcohol research and health, 26(2), 143–150.
Abstract: Problematic gambling is more common among people with alcohol use disorders (AUDs) (i.e., either alcohol abuse or dependence) compared with those without AUDs. This association holds true for people in the general population and is even more pronounced among people receiving treatment. No broadly accepted explanation for the link between problematic gambling and AUD currently exists. The available literature suggests that common factors may increase the risk for both conditions. For example, a defect of functioning in a particular brain system may underlie both conditions. This hypothesis should be further developed using brain imaging and psychopharmacological studies. Effective treatment and prevention will require additional research into relevant associations on both the event level (e.g., the effects of drinking on gambling behavior and vice versa) and the syndrome level (e.g., the relative onset and course of each condition among those who have either one or both disorders). A prudent interpretation of the available data suggests careful screening and treatment when necessary for problematic gambling among people with alcohol abuse and for alcohol abuse among people with gambling problems.
Keywords: pathological gambling; Aodd; comorbidity; etiology; diagnostic criteria; disinhibition; impulsive behavior; ventral tegmental area; encephalopathy; naltrexone; genetic linkage; causal path analysis; treatment outcome
|
Meili, B. (2004). Indizierte Prävention bei gefährdeten Jugendlichen. SuchtMagazin, 30(6; 12/2004), 21–25.
Abstract: Primärprävention von Drogenproblemen geniesst zwar nach wie vor hohe Legitimität, kann aber keine überzeugenden Wirkungserfolge nachweisen. Ein kritisches Überdenken dieser Sachlage ist unumgänglich und führt zu neuen Ansätzen wie beispielsweise zu indizierter Prävention.
Keywords: indicated prevention; adolescent; high-risk youth; journal article
|
various. (2010). Guidelines for collecting data on retail drug prices in Europe : issues and challenges (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 5. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the workings of drug supply mechanisms. They may also be used to help target law enforcement resources and assist criminal justice agencies with decisions related to prosecution and sentencing (e.g. assets recovery). The EMCDDA has been collecting information on retail drug prices via its Reitox focal points for the last 15 years. Although considerable progress has been made in this area, there is still variation in data collection in Europe. To address this issue, the EMCDDA has released these Guidelines for collecting data on retail drug prices in Europe: issues and challenges in its Manuals series. The Manual raises awareness on specific issues related to collecting data on retail drug prices and offers practical suggestions. It addresses difficulties in obtaining a definition of ’retail’ prices, and discusses the challenge of obtaining a representative sample of illicit, and therefore hidden, transactions. Suggestions are made for a minimum set of variables to be recorded for each observation. Targeted at all those involved in data collection on drug prices in Europe, the Manual reviews the main data-collection methods, current national practices and data-management issues.
Keywords: research; data collection; price and pricing; illicit drug; recommendations or guidelines; Europe
|
United Nations Office on Drugs and Crime (Ed.). (2013). International standards on drug use prevention. Vienna: United Nations Office on Drugs and Crime (UNODC).
Abstract: Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar spent on prevention, at least ten can be saved in future health, social and crime costs. These global International Standards summarize the currently available scientific evidence, describing interventions and policies that have been found to result in positive prevention outcomes and their characteristics. Concurrently, the global International Standards identify the major components and features of an effective national drug prevention system. It is our hope that the International Standards will assist policy makers worldwide to develop programmes, policies and systems that are a truly effective investment in the future of children, youth, families and communities. This work builds on and recognizes the work of many other organizations (e.g. EMCDDA, CCSA, CICAD, Mentor, NIDA, WHO) which have previously developed standards and guidelines on various aspects of drug prevention.
Keywords: AOD use; prevention; school-based prevention; family; community-based prevention; child; adolescent; poverty; health promotion; cost-benefit analysis; intervention (persuasion to treatment); recommendations or guidelines; quality; evaluation; literature review; international area; questionnaire
|
European Monitoring Centre for Drugs and Drug Addiction (Ed.). (2011). European drug prevention quality standards : a manual for prevention professionals. Manuals, 7. Luxembourg: Publications Office of the European Union.
Abstract: Prevention is one of the first approaches to be mentioned when public debate and policy address drug use and drug-related problems. Regularly, measures of prevention are presented as a means to overcome existing or future problems. However, evidence of ‘what works’ in practice is often overlooked. Similarly, research has shown examples where preventive efforts produced no or detrimental effects. This publication will help steer efforts in the right direction. Using an empirically derived reference framework, it bridges the gaps between science, policy and practice. Based on an overview of existing standards in Europe and beyond, a number of highly respected experts from EU Member States and international organisations worked together to prepare the publication. More than 400 national experts and stakeholders were included in a Delphi panel study and in a number of focus groups, which produced in-depth discussions as well as a consensus on the most important recommendations. The European Commission provided the funding for the original project on prevention standards and its results are now published within the EMCDDA Manuals series. In this series, information, advice, and guidance are offered to professionals and practitioners. Well structured and with many useful tables and figures, this publication will help its users as they progress from a first needs assessment to the delivery of an intervention and its final evaluation. Correct implementation of prevention measures with evidence-based components and anchoring them within existing structures and services (or activities) is key to ensuring effectiveness and it helps to avoid unintended iatrogenic effects. This manual will provide valuable guidance in this respect and allow preventive interventions to reach their full potential.
Keywords: AOD use, abuse, and dependence; prevention program; prevention; prevention strategy; quality; quality control; international area; Europe
|
various. (2012). Guidelines for the evaluation of drug prevention : a manual for programme planners and evaluators (European Monitoring Centre for Drugs and Drug Addiction, Ed.) (2nd ed.). Manuals, 8. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Prevention is a key consideration when discussing substance use and related problems. Drug prevention is any activity that delays or reduces the use of substances. Preventing substance use potentially makes other interventions, especially targeting treatment and harm reduction, unnecessary. Evaluation of the various interventions is essential to develop and improve existing approaches and to work towards creating a best practice in drug prevention. The EMCDDA first published the Guidelines for the evaluation of drug prevention in 1998 to respond to a need expressed by professionals and policymakers to have a tool and stimulus to evaluate prevention interventions in Europe. These guidelines aimed to facilitate and encourage project leaders to evaluate their own interventions and to design them accordingly. This second edition is an updated version of the original EMCDDA guidelines, which contains new methods, concepts and examples of currently available drug prevention interventions and which provides a framework for carrying out an evaluation. The content has also been updated with developments in online EMCDDA drug prevention and evaluation resources. Since publication of the first edition, prevention professionals who continue to apply these guidelines have contributed to the increased attention given to evaluation and prevention. However, although guidance on drug prevention is available in some Member States, only a minority of interventions in the European Union have an outcome evaluation. Even large, wellfunded projects are still not fully evaluated and the availability of empirical evidence concerning prevention is weak. These guidelines are intended for professionals working in the drug prevention and evaluation field and can provide valuable guidance when planning and evaluating prevention activities. The intention to develop best practice in drug prevention, as expressed in the 2005–8 and 2009–12 EU drugs action plans, and the fact that evaluation is now widely used in Member States’ drug policy, testify to the importance placed on drug prevention and evaluation in the European Union. The aim of this publication is to raise the profile of both drug prevention and evaluation methodologies and to provide prevention practitioners with an up-to-date framework, to enable their interventions and evaluations to reach their full potential.
Keywords: AOD use, abuse, and dependence; research; prevention; prevention outcome; prevention research; prevention directed at groups; recommendations or guidelines; Europe
|
Gumy, C., Gervasoni, J. - P., & Dubois-Arber, F. (2012). Evaluation de la 1ère année de mis en place du “pôle de valorisation des compétences sociales des usagers de drogue” géré par première ligne. rds, 189. Lausanne: Institut universitaire de médecine sociale et préventive (IUMSP); Unité dévaluation de programmes de prévention (UEPP).
Abstract: Première ligne est une association genevoise oeuvrant pour la réduction des risques liés à la toxicodépendance. Elle a mis en place un pôle de valorisation des compétences sociales des usagers de drogue (ci-après “le Pôle”) afin de lutter contre le désoeuvrement de ceux-ci. Ce nouveau “dispositif” a été basé sur des activités dites “petits jobs” déjà en place et d’autres à développer. Les objectifs principaux étant de valoriser les compétences des usagers de drogue, de leur permettre de travailler sur l’estime de soi et de se décentrer de la consommation. Le présent rapport porte sur l’évaluation du Pôle et d’une nouvelle activité, l’usager auxiliaire en salle de consommation.
Keywords: AOD dependence; health promotion; program evaluation; work; report; evaluation; Geneva
|
Arsever, S. (2001, 13.12.2001). Stupéfiants : Le Conseil des Etats laisse les cudées franches aux fumeurs de joints. Le Temps, 11.
Abstract: Première chambre à se pencher sur le texte, le Conseil des Etats accepte la proposition du gouvernement de dépénaliser la consommation de cannabis. Les producteurs de chanvre suisse pourront échapper aux poursuites s’ils se conforment à certaines règles et s’abstiennent de vendre à des mineurs. La prévention est renforcée.
Keywords: government and politics; harm reduction; legislative branch; legislative process; legal regulation; addiction; AOD dependence; chemical addiction; cannabis; Switzerland
|
Sami, R. (2011). Preisbindende Massnahmen bei Alkohol. SuchtMagazin, 37(1; 02/2011), 22–25.
Abstract: Preisbindende Massnahmen gelten als effiziente Werkzeuge gegen die problematische Verwendung von Alkohol. Der Fachverband Sucht hat die Studien zu dieser Frage gesichtet, reflektiert sie vor dem Hintergrund der aktuellen Revision des Alkoholgesetzes AlkG und stellt die entsprechenden politischen Forderungen.
Keywords: government and politics; AOD use, abuse, and dependence; alcohol; Switzerland; journal article
|
Office fédéral de la santé publique. (2008). Nouvel ouvrage pédagogique sur la violence sexuelle. Spectra : prévention et promotion de la santé, (69; 06/2008), 2.
Abstract: Prévention. Un nouvel ouvrage intitulé «Mit mir nicht. Mit dir nicht.» apporte un soutien précieux aux enseignants et spécialistes travaillant avec la jeunesse et désireux d’aborder la question de la violence sexuelle dans leurs classes et groupes de jeunes.
Keywords: prevention; sexual harassment; violence; child; adolescent; school context; Switzerland
|
